Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

Cited by (498)

Items 201–300 of 498

1. Diagnosis of small intestinal bacterial overgrowth: the challenges persist!
   Ahmed Abu-Shanab, Eamonn M.M. Quigley · 2009 · Expert Review of Gastroenterology & Hepatology
2. Rifaximin for Irritable Bowel Syndrome
   Jun Li, Wenhua Zhu, Wenhui Liu, Yingqiao Wu, Benyan Wu · 2016 · Medicine
3. The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders
   Peter R. Gibson, Jacqueline S. Barrett · 2010 · Nutrition
4. Pathogenic Factors Involved in the Development of Irritable Bowel Syndrome: Focus on a Microbial Role
   Carolina Bolino, Přemysl Berčík · 2010 · Infectious Disease Clinics of North America
5. Development of Irritable Bowel Syndrome Features Over a 5-year Period
   Clevers, Egbert, Tack, Jan, Törnblom, Hans, Ringström, Gisela, Luyckx, Koen, Simrén, Magnus, Van Oudenhove, Lukas · 2018 · Clinical Gastroenterology and Hepatology
6. Evaluating a Bacterial Hypothesis in IBS Using a Modification of Koch's Postulates: Part 1
   Mark Pimentel · 2010 · The American Journal of Gastroenterology
7. Duodenal Aspirates for Small Intestine Bacterial Overgrowth: Yield, PPIs, and Outcomes after Treatment at a Tertiary Academic Medical Center
   Diana L. Franco, Molly B. Disbrow, Allon Kahn, Laura M. Koepke, Lucinda A. Harris, M. Edwyn Harrison, Michael D. Crowell, Francisco C. Ramirez · 2015 · Gastroenterology Research and Practice
8. Fructose Malabsorption in Systemic Sclerosis
   Isabelle Marié, Anne‐Marie Leroi, Guillaume Gourcerol, Hervé Levesque, Jean-François Ménard, Philippe R. Ducrotte · 2015 · Medicine
9. Probiotics in functional bowel disorders
   Keren Hod, Yehuda Ringel · 2016 · Best Practice & Research Clinical Gastroenterology
10. Gastroduodenal “Dysbiosis”: a New Clinical Entity
    Ayesha Shah, Mark Morrison, Gerald Holtmann · 2018 · Current Treatment Options in Gastroenterology
11. UEG Week 2018 Poster Presentations
    Pittet, V., Aslan, N., Fournier, N., Decollogny, A., Schoepfer, A., Seibold, F., Rodondi, P.Y. · 2018 · United European Gastroenterology Journal
12. Role of small intestinal bacterial overgrowth in severe small intestinal damage in chronic non-steroidal anti-inflammatory drug users
    Motoko Muraki, Yasuhiro Fujiwara, Hirohisa Machida, Hirotoshi Okazaki, Mitsue Sogawa, Hirokazu Yamagami, Tetsuya Tanigawa, Masatsugu Shiba, Kenji Watanabe, Kazunari Tominaga et al. · 2014 · Scandinavian Journal of Gastroenterology
13. Rifaximin Treatment for Symptoms of Irritable Bowel Syndrome
    Andrea L. Fumi, Katherine M. Trexler · 2008 · Annals of Pharmacotherapy
14. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases
    Jasmohan Singh Bajaj, Giovanni Barbara, Herbert L. DuPont, Fermín Mearin, Antonio Gasbarrini, Jan F. Tack · 2018 · Digestive and Liver Disease
15. Antibiotics and Probiotics for Irritable Bowel Syndrome
    Vivek Chand Goodoory, Alexander Charles Ford · 2023 · Drugs
16. Successful treatment of asymptomatic or clinically terminal bovineMycobacterium aviumsubspeciesparatuberculosisinfection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone
    Robert E. Click · 2011 · Virulence
17. High-dose rifaximin treatment alleviates global symptoms of irritable bowel syndrome
    Jolley · 2011 · Clinical and Experimental Gastroenterology
18. Inflammation and Microflora
    Mark Pimentel, Christopher Chia-Chi Chang · 2011 · Gastroenterology Clinics of North America
19. Case–Control Research Study of Auto-Brewery Syndrome
    Barbara Jean Cordell, Anup K. Kanodia, Gregory K Miller · 2019 · Global Advances in Health and Medicine
20. More similarities than differences between men and women with irritable bowel syndrome
    Ida Björkman, Eva Jakobsson Ung, Gisela Ringström, Hans Törnblom, Magnus Simrén · 2015 · Neurogastroenterology & Motility
21. Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview
    Theodor Bokic, Martin Storr, Rudolf Schicho · 2015 · Pharmacology
22. Usefulness of Lactulose Breath Test for the Prediction of Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome
    Jung Soo Park, Jung Hwan Yu, Hyun Chul Lim, Jie‐Hyun Kim, Young Hoon Yoon, Hyojin Park, Sang In Lee · 2010 · Korean Journal of Gastroenterology
23. Increased TLR2 expression on blood monocytes in irritable bowel syndrome patients
    Lena Öhman, Ann-Charlotte Lindmark, Stefan Isaksson, Iris Posserud, Hans Strid, Henrik Sjövall, Magnus Simrén · 2012 · European Journal of Gastroenterology & Hepatology
24. Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease
    André Charlett, R. John Dobbs, Sylvia M. Dobbs, Clive Weller, Mohammad A. A. Ibrahim, Tracy K. Dew, Roy A Sherwood, Norman L. Oxlade, Jane Plant, James Bowthorpe et al. · 2009 · Gut Pathogens
25. The effects and mechanism of action of methane on ileal motor function
    Park, Y. M., Lee, Y. J., Hussain, Z., Lee, Y. H., Park, H. · 2017 · Neurogastroenterology & Motility
26. Breath test for differential diagnosis between small intestinal bacterial overgrowth and irritable bowel disease: An observation on non-absorbable antibiotics
    Esposito, I · 2007 · World Journal of Gastroenterology
27. Microbiota, infecciones gastrointestinales, inflamación de bajo grado y antibioticoterapia en el síndrome de intestino irritable. Una revisión basada en evidencias
    Schmulson, M., Bielsa, M.V., Carmona-Sánchez, R., Hernández, A., López-Colombo, A., López Vidal, Y., Peláez-Luna, M., Remes-Troche, J.M., Tamayo, J.L., Valdovinos, M.A. · 2014 · Revista de Gastroenterología de México
28. The Role of Diagnostic Testing in Irritable Bowel Syndrome
    David Furman, Brooks D. Cash · 2011 · Gastroenterology Clinics of North America
29. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets
    Gun-Ha Kim, Kihyun Lee, Jung Ok Shim · 2023 · Microbiology Spectrum
30. Probiotic Bacteria and Enteric Infections
    Paton, A., Morona, R., Paton, J. · 2011 · Springer eBooks
31. Lower gastrointestinal functions
    Adil E. Bharucha · 2008 · Neurogastroenterology & Motility
32. An evidence-based update on the diagnosis and management of irritable bowel syndrome
    Black, Christopher J., Ford, Alexander C. · 2025 · Expert Review of Gastroenterology & Hepatology
33. Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: A retrospective study of 932 patients
    Richard A Schatz, Qing Zhang, Nilesh Lodhia, Jonathan J. Shuster, Phillip P. Toskes, Baharak Moshiree · 2015 · World Journal of Gastroenterology
34. Irritable bowel syndrome: Bacteria and inflammation—Clinical relevance now
    Robert E. Spiller · 2007 · Current Treatment Options in Gastroenterology
35. Irritable bowel syndrome: diagnostic approaches in clinical practice
    Burbige · 2010 · Clinical and Experimental Gastroenterology
36. Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation
    Francesca Romana Ponziani, Silvia Pecere, Loris Riccardo Lopetuso, Franco Scaldaferri, Giovanni Cammarota, Antonio Gasbarrini · 2016 · Expert Opinion on Drug Safety
37. Probiotics and Irritable Bowel Syndrome
    Giovanni Barbara, Vincenzo Stanghellini, Cesare Cremon, Roberto DE GIORGIO, Luciana Gargano, Rosanna Francesca Cogliandro, Francesca Pallotti, Roberto Corinaldesi · 2008 · Journal of Clinical Gastroenterology
38. Lactulose breath test results in patients with persistent abdominal symptoms followingGiardia lambliainfection
    Mette Helvik Morken, Gunnar Nysæter, Elisabeth Astrup Strand, Trygve Hausken, Arnold Berstad · 2008 · Scandinavian Journal of Gastroenterology
39. Efficient diagnosis of suspected functional bowel disorders
    Jenny Gunnarsson, Magnus Simrén · 2008 · Nature Clinical Practice Gastroenterology & Hepatology
40. Role of NLRP3 inflammasome inBifidobacterium longum-regulated visceral hypersensitivity of postinfectious irritable bowel syndrome
    Qiaoyan Gu, Jun Zhang, Yichao Feng · 2015 · Artificial Cells Nanomedicine and Biotechnology
41. Review: Do probiotics improve symptoms in patients with irritable bowel syndrome?
    Peter James Whorwell · 2009 · Therapeutic Advances in Gastroenterology
42. Rational investigations in irritable bowel syndrome
    Christopher J. Black, Alexander Charles Ford · 2019 · Frontline Gastroenterology
43. Review article: Diagnosis and investigation of irritable bowel syndrome
    Christopher J. Black · 2021 · Alimentary Pharmacology & Therapeutics
44. New Treatments for Irritable Bowel Syndrome in Women
    Mopelola A. Adeyemo, Lin Chang · 2008 · Women s Health
45. Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease
    Andre Fialho, Andrea B. C. Fialho, Gursimran Singh Kochhar, Aldo L. Schenone, Prashanti N. Thota, Arthur J. McCullough, Bo Shen · 2017 · Digestive Diseases and Sciences
46. Gut microbiota: an Indicator to Gastrointestinal Tract Diseases
    Trupti Patel, Priyanjali Bhattacharya, Suvrajit Das · 2016 · Journal of Gastrointestinal Cancer
47. Factor Analysis Demonstrates a Symptom Cluster Related to Methane and Non-methane Production in Irritable Bowel Syndrome
    Marc D. Makhani, Janet Miyoung Yang, James Mirocha, Kimberly Low, Mark Pimentel · 2010 · Journal of Clinical Gastroenterology
48. Irritable bowel syndrome; update on pathophysiology and management
    Eamonn M.M. Quigley, Orla F. Craig · 2012 · The Turkish Journal of Gastroenterology
49. Recent developments in the therapy of irritable bowel syndrome
    Saad, Richard J, Chey, William D · 2008 · Expert Opinion on Investigational Drugs
50. Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iran.
    Mehdi Hayatbakhsh Abbasi, Mohammad Javad Zahedi, Sodaif Darvish Moghadam, Sara Shafieipour, Mahroo HayatBakhsh Abbasi · 2015 · Europe PMC (PubMed Central)
51. Associations between medication use and functional gastrointestinal disorders: a population‐based study
    Rok Seon Choung, G. Richard Locke, Cathy D. Schleck, Alan R. Zinsmeister, Nicholas J. Talley · 2013 · Neurogastroenterology & Motility
52. A 51-Year-Old With Irritable Bowel Syndrome: Test or Treat for Bacterial Overgrowth?
    Eamonn M.M. Quigley · 2007 · Clinical Gastroenterology and Hepatology
53. Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcripts
    Carsten Schmidt, Winfried Häuser, Thomas Giese, Andreas Stallmach · 2007 · Inflammatory Bowel Diseases
54. Expression of TRP Channels in Colonic Mucosa of IBS-D Patients and Its Correlation with the Severity of the Disease
    Li Cheng, Qingqing Luo, Shengliang Chen · 2022 · Gastroenterology Research and Practice
55. Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome
    Joost P. Algera, Esther Colomier, Chloé Melchior, Jóhann P. Hreinsson, Irina Midenfjord, Egbert Clevers, Magnus Simrén, Hans Törnblom · 2022 · Neurogastroenterology & Motility
56. ‘Brain Fogginess’ and D-Lactic Acidosis: Probiotics Are Not the Cause
    Eamonn M.M. Quigley, Bruno Pot, Mary Ellen Sanders · 2018 · Clinical and Translational Gastroenterology
57. RETRACTED ARTICLE: Gut microbiota and related diseases: clinical features
    Vincenzo Stanghellini, Giovanni Barbara, Cesare Cremon, Rosanna Francesca Cogliandro, Alexandra Antonucci, Veronica Gabusi, Chiara Frisoni, Roberto DE GIORGIO, Valentina Grasso, Mauro Serra et al. · 2010 · Internal and Emergency Medicine · Retracted
58. Rifaximin for the treatment of irritable bowel syndrome
    Filippo Cremonini, Anthony J Lembo · 2012 · Expert Opinion on Pharmacotherapy
59. Comparison of jejunal aspirate culture and methane and hydrogen breath test in the diagnosis of small intestinal bacterial overgrowth
    Shuai Tang, Jia Li, Jinxia Ma, Yi Li, Yuying Li, Jun Wan, Ru Zhang · 2023 · Irish Journal of Medical Science (1971 -)
60. Motility response to colonic distention is increased in postinfectious irritable bowel syndrome ( PI ‐ IBS )
    Motoyori Kanazawa, Olafur Steinn Palsson, Miranda A.L. van Tilburg, Lisa M. Gangarosa, Shin Fukudo, William E. Whitehead · 2014 · Neurogastroenterology & Motility
61. The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards?
    M. Di Stefano, Eamonn M.M. Quigley · 2018 · Neurogastroenterology & Motility
62. Defining Dysbiosis in Disorders of Movement and Motivation
    Christopher T. Fields, Timothy Robert Sampson, Annadora J. Bruce‐Keller, Drew D. Kiraly, Elaine Y. Hsiao, Geert J. De Vries · 2018 · Journal of Neuroscience
63. Treating the Metabolic Syndrome by Fecal Transplantation—Current Status
    Stephen D. H. Malnick, David L. Fisher, Marina Somin, Manuela G. Neuman · 2021 · Biology
64. Fecal microbiome differs between patients with systemic sclerosis with and without small intestinal bacterial overgrowth
    Daniel Levin, Giada De Palma, Hannah Zou, Ava Hadi Zadeh Bazzaz, Elena Francisca Verdu, Barbara Baker, María Inés Pinto-Sánchez, NADER A. KHALIDI, MAGGIE J. LARCHÉ, KAREN A. BEATTIE et al. · 2021 · Journal of Scleroderma and Related Disorders
65. An Evidence-Based Treatment Algorithm for IBS Based on a Bacterial/SIBO Hypothesis: Part 2
    Mark Pimentel · 2010 · The American Journal of Gastroenterology
66. Small intestinal bacterial overgrowth
    Aurora Parodi, Ernesto Cristiano Lauritano, Gerardo Nardone, L. Fontana, Vincenzo Savarino, Antonio Gasbarrini · 2009 · Digestive and Liver Disease Supplements
67. Irritable bowel syndrome – Diarrhoea
    Arnold M. Wald · 2012 · Best Practice & Research Clinical Gastroenterology
68. Associations between irritable bowel syndrome and non-alcoholic fatty liver disease: A systematic review
    Jareth Jun Jie Ng, Wai Mun Loo, Kewin Tien Ho Siah · 2023 · World Journal of Hepatology
69. Rifaximin in the Treatment of Irritable Bowel Syndrome
    David J. Farrell · 2013 · Journal of Clinical Gastroenterology
70. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
    I Moraru, Piero Portincasa, Alexandra Moraru, Mihai-Mircea Diculescu, Dan Lucian Dumitrascu · 2013 · PubMed
71. Review: Do patients with functional gastrointestinal disorders have an altered gut flora?
    Eamonn M.M. Quigley · 2009 · Therapeutic Advances in Gastroenterology
72. Bloating and Abdominal Distention: Not So Poorly Understood Anymore!
    Magnus Simrén · 2009 · Gastroenterology
73. Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin
    Christopher Chang · 2018 · Clinical and Experimental Gastroenterology
74. The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study
    Seok‐Hoon Lee, Nam‐Seok Joo, Kwang‐Min Kim, Kyu-Nam Kim · 2018 · Gastroenterology Research and Practice
75. Lactose Sensitivity and Lactose Malabsorption: The 2 Faces of Lactose Intolerance
    Michel L. Bouchoucha, M. Fysekidis, Pierre Rompteaux, Jean‐Jacques Raynaud, Jean‐Marc Sabaté, Robert Benamouzig · 2020 · Journal of Neurogastroenterology and Motility
76. Relationships Among the Lactulose Breath Test, Intestinal Gas Volume, and Gastrointestinal Symptoms in Patients with Irritable Bowel Syndrome
    Young Hoon Youn, Jung Soo Park, Jae Hoon Jahng, Hyun Chul Lim, Jie‐Hyun Kim, Mark Pimentel, Hyojin Park, Sang In Lee · 2011 · Digestive Diseases and Sciences
77. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model
    Binrui Chen, Shuwen Zhu, Lijun Du, Huiqin He, John J. Kim, Ning Dai · 2017 · Scandinavian Journal of Gastroenterology
78. The Efficacy of Probiotics in IBS
    Eamonn M.M. Quigley · 2008 · Journal of Clinical Gastroenterology
79. Predictors of Small Intestinal Bacterial Overgrowth in Symptomatic Patients Referred for Breath Testing
    Jeremy Liu Chen Kiow, Ratiba Bellila, Amélie Therrien, Sacha Sidani, Mickaël Bouin · 2020 · Journal of Clinical Medicine Research
80. Small-bowel aspiration during upper esophagogastroduodenoscopy: Rao technique
    Tennekoon B. Karunaratne, Amol Sharma, Satish S.C. Rao · 2020 · VideoGIE
81. Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H2 or CH4 production with severity of IBS
    Philippe Onana Ndong, Hanae Boutallaka, Eugènia Mariné–Barjoan, Dann Joseph Ouizeman, Raja Mroue, Rodolphe Anty, Geoffroy Vanbiervliet, Thierry Piche · 2023 · JGH Open
82. Risk Factors Associated With Upper Aerodigestive Tract or Coliform Bacterial Overgrowth of the Small Intestine in Symptomatic Patients
    Matthew E. Bohm, Andrea Shin, Sean Teagarden, Huiping Xu, Anita Gupta, Robert M. Siwiec, David E. Nelson, John M. Wo · 2018 · Journal of Clinical Gastroenterology
83. Targeted therapies for diarrhea-predominant irritable bowel syndrome
    Kevin W. Olden · 2012 · Clinical and Experimental Gastroenterology
84. Erosive esophagitis may be related to small intestinal bacterial overgrowth
    Kwang‐Min Kim, Bom-Taeck Kim, Duck-Joo Lee, Sat-Byul Park, Nam‐Seok Joo, Young‐Sang Kim, Kyu-Nam Kim · 2012 · Scandinavian Journal of Gastroenterology
85. Diagnosis of Irritable Bowel Syndrome: a Systematic Review
    Jung Ho Park, Jeong‐Sik Byeon, Woon-Geon Shin, Young Hun Yoon, Jae Hee Cheon, Kwang Jae Lee, Hyojin Park, The Korean Society of Neurogastroenterology and Motility · 2010 · Korean Journal of Gastroenterology
86. Association between small intestinal bacterial overgrowth and deep vein thrombosis
    Andre Fialho, Andrea B. C. Fialho, Aldo L. Schenone, Prashanthi Nagavenkata Thota, Arthur J. McCullough, Bo Shen · 2016 · Gastroenterology report
87. 10.1538/expanim.63.415
    xxxxxxxxxx xxxxxxxxxx · 2014 · EXPERIMENTAL ANIMALS
88. What is the evidence for the use of probiotics in functional disorders?
    Eamonn M.M. Quigley · 2008 · Current Gastroenterology Reports
89. Acknowledgements
    Cristina Almansa, Anurag K. Agrawal, Lesley Anne Houghton · 2012 · Expert Review of Gastroenterology & Hepatology
90. Natural History of Chronic Intestinal Pseudo-obstruction and Need for Palliative Care
    Kosuke Tanaka, Hidenori Ohkubo, Atsushi Yamamoto, Kota Takahashi, Yuki Kasai, Anna Ozaki, Michihiro Iwaki, Takashi Kobayashi, Tsutomu Yoshihara, Noboru Misawa et al. · 2023 · Journal of Neurogastroenterology and Motility
91. Poor predictive value of breath hydrogen response for probiotic effects in IBS
    Chu K Yao, Jacqueline S. Barrett, Hamish Philpott, Alvin Chung, Daniel R. van Langenberg, Mayur Garg, Peter R. Gibson · 2015 · Journal of Gastroenterology and Hepatology
92. Predicting a Response to Antibiotics in Patients with the Irritable Bowel Syndrome
    Rafid Kasir, Salam F. Zakko, Philip Zakko, Michael Adler, Aaron Lee, Sachin Dhingra, Cecile F. Guttermuth · 2015 · Digestive Diseases and Sciences
93. Small intestinal bacterial overgrowth as an uncommon cause of false positive lactose hydrogen breath test among patients with diarrhea‐predominant irritable bowel syndrome in A sia
    Yilin Wang, Lishou Xiong, Xiaorong Gong, Weimin Li, Xiangsong Zhang, Minhu Chen · 2014 · Journal of Gastroenterology and Hepatology
94. Physiology of the Colon and Its Measurement
    Adil E. Bharucha, Michael Camilleri · 2019 · Elsevier eBooks
95. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
    David A. Katzka · 2008 · Yearbook of Gastroenterology
96. A Predictive Model to Estimate Cost Savings of a Novel Diagnostic Blood Panel for Diagnosis of Diarrhea-predominant Irritable Bowel Syndrome
    Mark Pimentel, Chris Purdy, Raf Magar, Ali Ranjideh Rezaie · 2016 · Clinical Therapeutics
97. Enteric Microbiota and Small Intestinal Bacterial Overgrowth
    Seamus O’Mahony, Fergus Shanahan · 2010 · Elsevier eBooks
98. Gut Microbial Diversity in Rat Model Induced by Rhubarb
    Ying B. Peng, Chunfu Wu, Jingyu Yang, Xiaobo Li · 2014 · EXPERIMENTAL ANIMALS
99. Rifaximin Therapy of Irritable Bowel Syndrome
    Hoonmo L. Koo, Saman Sabounchi, David B. Huang, Herbert L. DuPont · 2012 · Clinical Medicine Insights Gastroenterology
100. Colonic hypersensitivity is a major determinant of the efficacy of bloating treatment in constipation-predominant irritable bowel syndrome
     M. Di Stefano, P. Tana, C. Mengoli, E. Miceli, E. Pagani, G. Corazza · 2011 · Internal and Emergency Medicine